Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 30, 2013	Mar. 24, 2012
Cash flows from operating activities:
Net income	$ 240,516	$ 197,945
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	87,820	55,822
Amortization of intangibles	22,939	23,021
Amortization of deferred financing fees	3,025	3,025
Unrealized loss (gain) on foreign currency, net	7,178	(4,547)
Loss on disposal of fixed assets	241	1,265
Gain on sale of subsidiary, excluding transaction costs		(28,914)
Provision for doubtful accounts	(15)	1,656
Provision for sales returns	58,812	67,402
(Gain) loss on derivatives, net	(3,847)	3,580
Excess tax benefits from equity-based compensation plans	(9,563)	(11,172)
Deferred income taxes	2,901	8,325
Deferred compensation and stock compensation	15,214	9,336
Other	449	5
Changes in assets and liabilities:
Receivables	(9,827)	(55,546)
Inventories	177,665	72,671
Income tax receivable/payable, net	19,237	65,050
Other current assets	(7,861)	(17,871)
Other long-term assets, net	3,371	(436)
Accounts payable, accrued expenses and accrued compensation costs	3,721	(17,474)
Other current liabilities	(137)	(2,878)
Other long-term liabilities	(7,154)	(109)
Net cash provided by operating activities	604,685	370,156
Cash flows from investing activities:
Change in restricted cash	3,013	665
Proceeds from sale of subsidiary, net of cash transferred		137,733
Capital expenditures for fixed assets	(148,349)	(204,556)
Other investing activities	231	444
Net cash used in investing activities	(145,105)	(65,714)
Cash flows from financing activities:
Net change in revolving line of credit	(184,949)	(182,814)
Proceeds from issuance of common stock under compensation plans	9,334	2,228
Repurchase of common stock	(125,681)
Excess tax benefits from equity-based compensation plans	9,563	11,172
Payments on capital lease and financing obligations	(1,547)	(3,148)
Repayment of long-term debt	(3,391)	(4,552)
Other financing activities	(549)	(149)
Net cash used in financing activities	(297,220)	(177,263)
Change in cash balances included in current assets held for sale		5,160
Effect of exchange rate changes on cash and cash equivalents	521	675
Net increase in cash and cash equivalents	162,881	133,014
Cash and cash equivalents at beginning of period	58,289	12,989
Cash and cash equivalents at end of period	221,170	146,003
Supplemental disclosures of cash flow information:
Fixed asset purchases included in accounts payable and not disbursed at the end of each period	21,437	44,672
Noncash investing and financing activities:
Fixed assets acquired under capital lease and financing obligations	11,769	44,174
Settlement of acquisition related liabilities through release of restricted cash	$ 9,227	$ 18,788